Cargando…
Chip-based digital Polymerase Chain Reaction as quantitative technique for the detection of PIK3CA mutations in breast cancer patients
BACKGROUND: PIK3CA is a gene frequently mutated in breast cancer. With the FDA approval of alpelisib, the evaluation of PIK3CA for activating mutations is becoming routinely. Novel platforms for gene analysis as digital PCR (dPCR) are emerging as a potential replacement for the traditional Sanger se...
Autores principales: | Giannoni-Luza, Stefano, Acosta, Oscar, Murillo Carrasco, Alexis Germán, Danos, Pierina, Cotrina Concha, José Manuel, Guerra Miller, Henry, Pinto, Joseph A., Aguilar, Alfredo, Araujo, Jhajaira M., Fujita, Ricardo, Buleje, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650006/ https://www.ncbi.nlm.nih.gov/pubmed/36387506 http://dx.doi.org/10.1016/j.heliyon.2022.e11396 |
Ejemplares similares
-
PUM1 and RNase P genes as potential cell‐free DNA markers in breast cancer
por: Murillo Carrasco, Alexis, et al.
Publicado: (2021) -
Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer
por: Buleje, Jose, et al.
Publicado: (2017) -
PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report
por: Valencia, Guillermo Arturo, et al.
Publicado: (2021) -
Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013) -
Association between PIK3CA Mutations in Blood and Tumor-Infiltrating Lymphocytes in Peruvian Breast Cancer Patients
por: Castaneda, Carlos A., et al.
Publicado: (2022)